Retinal involvement in systemic lupus erythematosus PV Nangia, L Viswanathan, R Kharel, J Biswas Lupus Open Access 2 (1000129), 2, 2017 | 15 | 2017 |
The complex role of leptin in SLE: is leptin a key link between metabolic syndrome, accelerated atherosclerosis and autoimmunity D Margiotta, M Vadacca, L Navarini, F Basta, A Afeltra Lupus Open Access 1 (1), 107, 2016 | 14 | 2016 |
Catastrophic antiphospholipid syndrome in combination with SLE treated by Rituximab: a case report and literature review EM Elagib, NIA Eltahir, MEA Essa Adam, MD Yousif Haron, ZIT Mahmoud, ... Lupus: Open Access 4 (1), 137, 2019 | 9 | 2019 |
Immunoadsorption in Buerger’s disease (thromboangiitis obliterans): a promising therapeutic option: results of a consecutive patient cohort treated in clinical routine care P Klein-Weigel, T Volz, B Gutsche-Petrak, J Boehnlein, A Bohlen, ... Lupus Open Access 1 (114), 2, 2016 | 8 | 2016 |
Lupus erythematosus profundus: a case series and review of literature DP Thapa, R Kubba, A Kubba Lupus Open Access 3 (1), 1-5, 2018 | 4 | 2018 |
Antigen-microarray profiling of antibodies in SLE: a personal view of translation from basic science to the clinic IR Cohen Lupus Open Access 1 (3), 118, 2016 | 4 | 2016 |
A possible interconnection of cholesterol overloading and phagocytic activity of the monocytes in the prone to rheumatoid arthritis individuals M Arleevskaya, A Zabotin, A Gabdoulkhakova, J Filina, A Tsibulkin Lupus Open Access 1 (112), 2, 2016 | 4 | 2016 |
The influence of GSTA1 polymorphism to the response to intravenous cyclophosphamide therapy in the lupus nephritis patients H Wang, XY Zhu, Y Zhu, M Zhao, YC Chen Lupus Open Access 1 (115), 2, 2016 | 3 | 2016 |
Malariotherapy: the old-renewed immunotherapeutic candidate for systemic lupus erythematosus MA Abdel-Maksoud, S Al-Quraishy Lupus Open Access 4 (2), 1-4, 2019 | 2 | 2019 |
SLE: Unusual recombinant monoclonal light chain ngta3-pro-dnase possessing three different activities trypsin-like, metalloprotease and DNase AM Timofeeva, VN Buneva, GA Nevinsky Lupus: Open Access 2 (2), 1-12, 2017 | 2 | 2017 |
Importance of disease activity indices in Indian rheumatoid arthritis (RA) patients of Western region SC Borukar, AR Chogle, SS Deo Lupus 1, 117, 2016 | 2 | 2016 |
Update on immune mechanisms in systemic lupus and lupus nephritis S Devarapu, H Anders, K Rupanagudi Lupus Open Access 1 (116), 2, 2016 | 2 | 2016 |
Clinical continuum of spstemic lupus in Saudi Arabia A Khan, N Abid, R Khawaja Lupus Open Access 1 (113), 2, 2016 | 2 | 2016 |
Malaga study: 25 Year background in lupus nephritis in south of Spain MA Martin-Gomez, MAF Sanz, EDR Garrido Lupus Open Access 1, 1, 2016 | 2 | 2016 |
Using the SLE-key Rule-Out test in clinical practice D Massenburg, J Oldenbrug, A Sell, T Krause, AF Wells Lupus Open Access 2 (126), 2, 2017 | 1 | 2017 |
Multiple Pulmonary and Splenic Infarcts Triggered by Acute CMV Infection and Transient Double Antiphospholipid Antibody Positivity in a Patient Carrier for JAK-2 Mutation Lupus … E Esteve-Valverde, M Bonet-Álvarez, MA Baraldès-Farré, J Alijotas-Reig doi 10.35248/2684-1630.16. 1.101, 0 | 1 | |
Effect of Known and Previously Undiagnosed Undifferentiated Connective Tissue Diseases on Pregnancy Outcome B Fausta, L Elena, C Chiara, R Véronique, B Camilla, DM Irene Lupus: Open Access 4, 140, 2019 | | 2019 |
Anti-KIR Antibodies Treat Lupus in Mice FM Strickland, KJ Johnson, BC Richardson Lupus: Open Access 4, 138, 2019 | | 2019 |
Systemic Lupus Erythematodes (SLE) Patient with an Unexpected Finding: Case Report J Weinmann-Menke, M Dörken, S Boedecker, A Kreft, M Dennebaum, ... Lupus: Open Access 4, 136, 2019 | | 2019 |
Genetic Variation at the DNASE I Locus in an Australian Cohort of SLE Patients AA Margery-Muir, JD Wetherall, DM Groth Lupus Open Access 3 (130), 2, 2018 | | 2018 |